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ABSTRACT
Context: Phytochemical and pharmacological data on Ducrosia anethifolia (DC.) Boiss. (Apiaceae), an
Iranian medicinal plant, are scarce; however, furocoumarins are characteristic compounds of D. anethifolia.
Objective: Our experiments identify the secondary metabolites of D. anethifolia and assess their antitu-
mor and anti-multidrug resistance activities.
Materials and methods: Pure compounds were isolated from the extract of aerial parts of the plant by
chromatographic methods. Bioactivities were tested on multidrug resistant and sensitive mouse T-lymph-
oma cell lines. The inhibition of the cancer MDR efflux pump ABCB1 was evaluated by flow cytometry (at
2 and 20 mM). A checkerboard microplate method was applied to study the interactions of furocoumarins
and doxorubicin. Toxicity was studied using normal murine NIH/3T3 fibroblasts.
Results: Thirteen pure compounds were isolated, nine furocoumarins namely, pabulenol (1), (þ)-oxypeuce-
danin hydrate (2), oxypeucedanin (3), oxypeucedanin methanolate (4), ()-oxypeucedanin hydrate (5),
imperatorin (6), isogospherol (7), heraclenin (8), heraclenol (9), along with vanillic aldehyde (10), harmine
(11), 3-hydroxy-a-ionone (12) and 2-C-methyl-erythrytol (13). Oxypeucedanin showed the highest in vitro
antiproliferative and cytotoxic activity against parent (IC50 ¼ 25.98± 1.27, 40.33 ± 0.63 mM) and multidrug
resistant cells (IC50 ¼ 28.89 ± 0.73, 66.68 ± 0.00mM), respectively, and exhibited slight toxicity on normal
murine fibroblasts (IC50 ¼ 57.18± 3.91mM).
Discussion and conclusions: Compounds 2, 3, 5, 7, 10–13 were identified for the first time from the
Ducrosia genus. Here, we report a comprehensive in vitro assessment of the antitumor activities of D. ane-
thifolia furocoumarins. Oxypeucedanin is a promising compound for further investigations for its anti-
cancer effects.
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The genus Ducrosia (Apiaceae) consists of six species: Ducrosia
ismaelis Asch., D. flabellifolia Boiss., D. assadii Alava., D. areysiana
(Deflers) Pimenov & Kljuykov, D. inaccessa (C.C.Towns.) Pimenov
& Kljuykov and D. anethifolia (DC.) Boiss. D. anethifolia is one of
the three species growing wild in several areas of Iran,
Afghanistan, Pakistan, Syria, Lebanon, Iraq, and some other Arab
states and countries along the Persian Gulf (Aynehchi 1991;
Ghahreman 1993; Mozaffarian 1996). The whole herb, especially
its aerial part, has been used in Iranian folk medicine as an anal-
gesic and in case of anxiety and insomnia (Shalaby et al. 2014).
The aerial part, including the seed was reported to be carminative
and useful for irregularities of menstruation and galactagogue
(Amiri and Joharchi 2016). The herb is added to a variety of
Persian foods for flavouring (Aynehchi 1991; Haghi et al. 2004).
The phytochemical profile of D. anethifolia has only been
partly explored. In the literature, the majority of papers deal
with the composition of the essential oil (EO). As major constit-
uents, a-pinene (11.6% (Mostafavi et al. 2008), 70.3%
(Mottaghipisheh et al. 2014), 59.2% (Janssen et al. 1984)); n-
decanal (1.4-45% (Karami and Bohlooli 2017), 45.06%
(Vazirzadeh et al. 2017), 70% (Hajhashemi et al. 2010), 57%
(Mahboubi and Feizabadi 2009), 25.6–30.3% (Mazloomifar and
Valian 2015), 18.8% (Sefidkon and Javidtash 2002)), dodecanal
(28.8% (Shahabipour et al. 2013)), cis-chrysanthenyl acetate
(72.28%) (Ashraf et al. 1979; Habibi et al. 2017) have
been reported.
Furocoumarins and terpenoids are characteristic components
of the Ducrosia genus. From the seeds of D. anethifolia, two new
terpenoids, the monoterpene ducrosin A and the sesquiterpene
ducrosin B were isolated along with stigmasterol and the furo-
coumarins heraclenin and heraclenol (Queslati et al. 2017).
Psoralen, 5-methoxypsoralen, 8-methoxypsoralen, imperatorin,
isooxypeucedanin, pabulenol, pangelin, oxypeucedanin methano-
late, oxypeucedanin hydrate, 3-O-glucopyranosyl-b-sitosterol and
8-O-debenzoylpaeoniflorin were also isolated from the extract of
D. anethifolia (Stavri et al. 2003; Shalaby et al. 2014). GC analysis
of the fatty acids showed high percentages of elaidic acid and
oleic acid (Queslati et al. 2017), beside 58.8% petroselinic acid in
the seed oil of D. anethifolia (Khalid et al. 2009). Apart from
D. anethifolia, furocoumarins (psoralen, isopsoralen) have been
reported only from D. ismaelis from this genus (Morgan
et al. 2015).
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The bioactivities of the extracts of aerial parts of D. anethifo-
lia have been studied in vitro and in vivo. Different extracts of
the plant exerted moderate anti-radical scavenging
(Mottaghipisheh et al. 2014; Shahat et al. 2015); and antibacterial
effects (Syed et al. 1987; Mahboubi and Feizabadi 2009).
Pangelin isolated from D. anethifolia demonstrated activity
against a panel of fast growing mycobacteria (Stavri et al. 2003).
Essential oil of the seeds and methanol extract showed a weak
antibacterial effect against 14 Gram positive and negative bac-
teria (Javidnia et al. 2009; Habibi et al. 2017). In an experiment
on three human cancer cell lines (K562, LS180 and MCF-7), D.
anethifolia EO demonstrated remarkable to moderate cytotoxic
activity, while EO of D. flabellifolia showed less pronounced
activity (Shahabipour et al. 2013). Ducrosin B exerted remarkable
cytotoxicity against the human colon HCT-116 and ovary
SKOV-3 cancer cell lines in vitro (Queslati et al. 2017).
The crude D. anethifolia extract and the isolated furocoumar-
ins exhibited in vivo antidiabetic activities (Shalaby et al. 2014).
The in vivo anxiolytic (Hajhashemi et al. 2010; Shokri et al.
2013; Zamyad et al. 2016), sedative (Hajhashemi et al. 2010),
analgesic and anti-inflammatory (Asgari Nematian et al. 2017)
and also anti-locomotor activities (Zamyad et al. 2016) of D. ane-
thifolia EO have been tested. Intra-peritoneal administration of
the D. anethifolia EO improved spatial learning and memory in
adult male rats (Abbasnejad et al. 2017). The intra-peritoneal
injection of the hydroalcoholic extract of D. anethifolia effectively
reduced the pentylenetetrazole-induced seizure manifestations in
male Wistar rats (Nyasty et al. 2017). Moreover, D. anethifolia
extract reduced the number of germ cells, the level of testoster-
one and spermatogenesis in male Wistar rats (Rahimi
et al. 2016).
As presented above, furocoumarins are the most characteristic
compounds of the Ducrosia and their activities against cancer
cells seem to be promising. Imperatorin showed antiproliferative
effect on human hepatoma HepG2 cells (Luo et al. 2011); fur-
thermore, this compound and heraclenin induced apoptosis in
Jurkat leukemia cells. In Jurkat cells treated for 72 h with hera-
clenin and imperatorin, most of the DNA fragmentation
occurred at the G2/M and G1/S phases of the cell cycle, respect-
ively (Appendino et al. 2004). 8-Methoxypsoralen inhibited the
growth of neuroblastoma (IC50¼ 56.3 mM) and metastatic colon
cancer cells (IC50¼ 88.5 mM) by triggering both extrinsic and
intrinsic apoptotic pathways, independently of photoactivation
(Bartnik et al. 2017). Isoimperatorin, cnidicin, imperatorin, oxy-
peucedanin, byakangelicol and oxypeucedanin hydrate exhibited
a significant inhibition on cell proliferation in a dose-dependent
manner, particularly oxypeucedanin against HCT-15 (colon can-
cer) cells with ED50¼ 3.4 ± 0.3 lg/mL (Kim et al. 2007).
Beside direct antiproliferative and cytotoxic activities, furocoumar-
ins affect multidrug resistance (MDR) as well. Among 20 selected
furocoumarin derivatives, phellopterin (IC50¼ 8.0± 4.0 mM) and iso-
pimpinellin (IC50¼ 26.0± 5.7 mM) exhibited the highest activity
against CEM/C1 (lymphoblastic leukaemia) and HL-60/MX2 (MDR)
cell lines, respectively (Kubrak et al. 2017). Feroniellin A reverted
MDR in A549RT-eto lung cancer cells (Kaewpiboon et al. 2014).
Bergapten (IC50¼ 40.29±0.30nM) and xanthotoxin (IC50¼ 1.10±
0.91nM) showed remarkable anticancer activity against EPG85.
257RDB (MDR1 overexpressing human gastric adenocarcinoma cell
line) and MCF7MX (BCRP overexpressing human epithelial breast
cancer cell line), respectively (Mirzaei et al. 2017).
Our work explores the phytochemical composition of D. ane-
thifolia, examines the complex in vitro anticancer activities,
including antiproliferative, cytotoxic and anti-MDR effects of its
isolated compounds, and analyses the interaction of compounds
possessing promising bioactivities with chemotherapeutics.
Materials and methods
General procedures
NMR spectra were recorded in CD3OD and CDCl3 on a Bruker
Avance DRX 500 spectrometer at 500MHz (1H) and 125MHz
(13C). The peaks of the residual solvent (dH 3.31 and 7.26, dC 49.0
and 77.2, respectively) were taken as reference. The data were
acquired and processed with MestReNova v6.0.2e-5475 software.
Chemical shifts are expressed in parts per million and coupling
constants (J) values are reported in Hz. All solvents were used in
analytical grade (Molar Chemicals Kft, Halasztelek, Hungary).
Pure compounds were isolated by using open column chroma-
tography (Silica gel 60, 0.063–0.2mm, Merck, Darmstadt,
Germany) (CC), medium pressure liquid chromatography (MPLC,
silica gel 60, 0.045–0.063mm, Merck, Darmstadt, Germany), gel
chromatography (SephadexVR LH-20, Pharmacia, Uppsala,
Sweden), normal (Silica gel 60, Merck, Darmstadt, Germany) and
reverse phase (Silica gel 60 RP-18 F254s, Merck, Darmstadt,
Germany) preparative thin layer chromatography (PTLC and RP-
PTLC, respectively), centrifugal PTLC (Silica gel 60 GF254, Merck,
Darmstadt, Germany) (CPTLC) and reverse phase preparative
HPLC (KinetexVR 5 mm C-18 100 Å, 150 4.6mm Phenomenex,
Torrance, CA) (RP-HPLC). The HPLC flow was 1.2mL/min, col-
umn oven temperature was 24 C. Detection was carried out within
the range of 190–800 nm. The HPLC system comprised of Waters
600 pump, Waters 2998 PDA detector, Waters in/line degasser AF
degasser unit connected with Waters 600 control module using
Empower Pro 5.00 software.
Plant material
The aerial parts of Ducrosia anethifolia were collected by JM
from south of Iran (Fars, Neyriz, Iran) in April 2016.
Identification of the plant was done by Dr. Mohammad Jamal
Saharkhiz at Department of Horticultural Science, Faculty of
Agriculture, Shiraz University, Iran, and a voucher specimen was
deposited in the Herbarium of Department of Pharmacognosy,
University of Szeged (voucher no.: 880).
Isolation of compounds
Aerial parts (flower, leaves and stem, 3 kg) were dried in shade
at room temperature and powdered, then extracted with metha-
nol (40 L). After filtration, the filtrate was concentrated under
reduced pressure to yield the crude extract. The extract (464.1 g)
was dissolved with methanol–water 1:1 (1.5 L) and then parti-
tioned successively with n-hexane (4 1 L), CHCl3 (4 1 L),
EtOAc (4 1 L) and n-BuOH (4 1 L). The solvents were
removed from each extract to yield the n-hexane extract, CHCl3
extract, EtOAc extract and n-BuOH extract.
The CHCl3-soluble fraction (20.6 g) was initially subjected to
CC with a gradient system consisting of increasing concentration
of MeOH in CHCl3 (0–80%); column fractions with similar TLC
patterns were combined to get six major fractions D1, D2, D3,
D4, D5 and D6. D1 was chromatographed by MPLC, first eluting
with n-hexane–CH2Cl2 (50:50; 0:100), then adding MeOH to
CH2Cl2 (0–100%), to afford four subfractions (D11, D12, D13 and
D14). D11 was separated to 49 subfractions using CPTLC with an
isocratic eluting system n-hexane–EtOAc–MeOH (10:3:1), which
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resulted in the isolation of the pure compound 6 (82.8mg). The
RP-HPLC purification of D11 subfractions with MeOH–H2O
(MeOH–H2O 1:1) afforded compound 10 (1.7mg). D12 was
chromatographed by MPLC applying a gradient solvent system
with increasing EtOAc in n-hexane (5-100%) to get eight major
subfractions (D121–D128). From D123, the pure compound 3
(3.1mg) was isolated by using CPTLC with EtOAc in n-hexane
(5–100%). D124 was successively separated to 81 fractions by
CPTLC (same system), then subfractions 49–54 was subjected to
RP-HPLC with MeOH–H2O (15–50% H2O in MeOH) yielding
compound 9 (2.56mg).
D13 was separated by MPLC with increasing ratio of EtOAc
in n-hexane (5–100%) to get seven fractions (D131–D137). D133
was subjected to MPLC with the same solvent system to gain 19
subfractions. Finally, subfractions 1–2 were purified by using
CPTLC with toluene–EtOAc (90:10, 80:20, 70:30, 60:40, 50:50) as
eluents to gain compound 2 (100.4mg). Subfraction 3 from D133
was subjected to CPTLC by eluting with toluene–EtOAc (90:10,
80:20, 70:30, 60:40, 50:50) to yield 32 subfractions. Subfractions
18–19 of D133 were separated by PTLC with toluene–EtOAc
(1:1) to get compound 8 (35.3mg). Besides, subfractions 23–32
were chromatographed by RP-HPLC (MeOH–H2O 1:1) and then
by PTLC with toluene–EtOAc (1:1) to yield compounds 12
(1.02mg) and 1 (1.78mg). By using CPTLC with increasing con-
centration of EtOAc in toluene (5–100%) as eluents, subfraction
6 from D133 was chromatographed to get 43 subfractions.
Subfractions 24–28 and 36–40 were separated by PTLC with
CHCl3–MeOH–n-hexane (5:1:5) to retrieve compounds 4
(2.5mg) and 7 (21.7mg), respectively.
D3 was separated to five major fractions (D31–D35) by MPLC
with a solvent system containing increasing ratio of MeOH in
CHCl3 (0–100%). D33 was chromatographed by CPTLC with
raising the concentration of MeOH (0–20%) in the mixture of
cyclohexane–EtOAc (1:1) to afford 70 subfractions. Subfractions
21–23 contained the pure compound 11 (1.0mg). The main frac-
tion D4 was separated by MPLC to seven subfractions (D41–D47)
by raising the ratio of MeOH (0–100%) in acetone–toluene (1:1).
Subfraction D42 was subsequently chromatographed by PTLC
with eluting cyclohexane–EtOAc–MeOH (4.75:4.75:0.5) and com-
pound 5 (2.7mg) was isolated. Furthermore, D46 was purified
with CPTLC by increasing ratio of MeOH (0–100%) in acetone–
toluene (1:1); then compound 13 (2.9mg) was purified by using
RP-PTLC [MeOH–H2O (1:1)] from subfractions 35–37
(Figure 1).
Cell lines
L5178Y mouse T-cell lymphoma cells: parent, PAR cells
(ECACC cat. no. 87111908, obtained from FDA, Silver Spring,
MD) were transfected with pHa MDR1/A retrovirus. The
ABCB1-expressing L5178Y cell line (MDR) was selected by cul-
turing the infected cells in 60 ng/mL colchicine containing
medium. L5178Y PAR mouse T-cell lymphoma cells and the
L5178Y human ABCB1-transfected subline (MDR) were cultured
in McCoy’s 5A medium supplemented with 10% heat-inactivated
horse serum, 200mM L-glutamine, and penicillin–streptomycin
mixture in 100U/L and 10mg/L concentration, respectively, at
37 C and in a 5% CO2 atmosphere.
NIH/3T3 mouse embryonic fibroblast cell line (ATCC CRL-
1658) was purchased from LGC Promochem (Teddington, UK).
The cell line was cultured in Dulbecco’s modified Eagle’s
medium (DMEM; Sigma-Aldrich, St. Louis, MO), containing
4.5 g/L glucose, supplemented with 10% heat-inactivated foetal
bovine serum (FBS). The cells were incubated at 37 C, in a 5%
CO2, 95% air atmosphere.
Assay for antiproliferative effect
The effects of increasing concentrations of the analysed com-
pounds on cell proliferation were tested in 96-well flat-bottomed
microtiter plates (Poljarevic et al. 2018). The compounds were
diluted in 100lL of McCoy’s 5A medium. 6 103 mouse T-cell
lymphoma cells (PAR or MDR) in medium (100lL) were added
to each well, with the exception of the medium control wells.
The culture plates were further incubated at 37 C for 72 h; at
the end of the incubation period, 20lL of MTT solution
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Figure 1. Secondary metabolites isolated from Ducrosia anethifolia.
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(thiazolyl blue tetrazolium bromide, Sigma, St. Louis, MO) (from
a 5mg/mL stock) was added to each well. After incubation at
37 C for 4 h, 100lL of sodium dodecyl sulphate (SDS, Sigma,
St. Louis, MO) solution (10% in 0.01 M HCl) was added to each
well and the plates were further incubated at 37 C overnight.
The cell growth was determined by measuring the OD at 540 nm
(ref. 630 nm) with a Multiscan EX ELISA reader (Thermo







Assay for cytotoxic effect
The effects of increasing concentrations of compounds on cell
growth were tested in 96-well flat-bottomed microtiter plates
(Poljarevic et al. 2018). The compounds were diluted in a volume
of 100 lL medium. Then, 1 104 cells in 100lL of medium
were added to each well, with the exception of the medium con-
trol wells. In case of NIH/3T3 cells, the compounds were added
after seeding the cells at 37 C overnight. The culture plates were
incubated at 37 C for 24 h; at the end of the incubation period,
20 lL of MTT solution (from a 5mg/mL stock) was added to
each well. After incubation at 37 C for 4 h, 100lL of SDS solu-
tion (10% in 0.01 M HCl) was added to each well and the plates
were further incubated at 37 C overnight. Cell growth was
determined by measuring the optical density (OD) at 540 nm
(ref. 630 nm) with a Multiscan EX ELISA reader. Inhibition of






Results are expressed in terms of IC50, defined as the inhibi-
tory dose that reduces by a 50% the growth of the cells exposed
to the tested compound.
Assay for multidrug resistance reversing activity
The inhibition of the cancer MDR efflux pump ABCB1 by the
tested compounds was evaluated using flow cytometry measuring
the retention of rhodamine 123 by ABCB1 (P-glycoprotein) in
MDR mouse T-lymphoma cells, as the L5178Y human ABCB1-
gene transfected mouse T-lymphoma cell line (MDR) overex-
presses P-glycoprotein (Domınguez-Alvarez et al. 2016). This
method is a fluorescence-based detection system which uses ver-
apamil as reference inhibitor. Briefly, cell number of L5178Y
MDR and PAR cell lines was adjusted to 2 106 cells/mL,
re-suspended in serum-free McCoy’s 5A medium and distributed
in 0.5mL aliquots into Eppendorf centrifuge tubes. The tested
compounds were added at different concentrations and the sam-
ples were incubated for 10min at room temperature. Verapamil
(Sigma, St. Louis, MO) and tariquidar (Sigma, St. Louis, MO)
were applied as positive controls. Next, 10 mL (5.2 mM final con-
centration) of the fluorochrome and ABCB1 substrate rhodamine
123 (Sigma, St. Louis, MO) were added to the samples and the
cells were incubated for 20min at 37 C, washed twice and re-
suspended in 0.5mL PBS for analysis. The fluorescence of the
cell population was measured with a Partec CyFlowVR flow
cytometer (Partec, G€orlitz, Germany). The percentage of mean
fluorescence intensity was calculated for the treated MDR cells as
compared with the untreated cells. A fluorescence activity ratio
(FAR) was calculated based on the following equation which
relates the measured fluorescence values:
FAR ¼ MDRtreated=MDRcontrol
parentaltreated=parentalcontrol
The results obtained from a representative flow cytometry
experiment in which 20,000 individual cells of the population
were evaluated for amount of rhodamine 123 retained with the
aid of the Partec CyFlowVR flow cytometer, are first presented by
the histograms and these data converted to FAR units that define
fluorescence intensity, standard deviation, peak channel in the
total- and in the gated-populations. Parameters calculated are:
forward scatter (FSC, forward scatter count of cells in the sam-
ples or cell size ratio); side scatter (SSC, side scatter count of
cells in the samples); FL-1 (mean fluorescence intensity of the
cells) and FAR, whose values were calculated using the equation
given above.
Checkerboard combination assay
A checkerboard microplate method was applied to study the
effect of drug interactions between furocoumarins and the che-
motherapeutic drug doxorubicin (Takacs et al. 2015). This assay
was carried out using multidrug resistant mouse T-lymphoma
cells overexpressing the ABCB1 transporter. Doxorubicin is in
the class of anthracycline antitumor agents, and it exerts anti-
cancer activity as a topoisomerase-II (TI-2) inhibitor. The dilu-
tions of doxorubicin (Teva, Debrecen, Hungary, stock solution:
2mg/mL) were made in a horizontal direction in 100lL (final
concentration: 17.242 lM), and the dilutions of the test com-
pounds vertically in the microtiter plate in 50 lL volume. The
cells were re-suspended in McCoy’s 5A culture medium and dis-
tributed into each well in 50 lL containing 6 103 cells each.
The plates were incubated for 72 h at 37 C in 5% CO2 atmos-
phere. The cell growth rate was determined after MTT staining.
At the end of the incubation period, 20 lL of MTT solution
(from a stock solution of 5mg/mL) was added to each well.
After incubation at 37 C for 4 h, 100lL of SDS solution (10% in
0.01 M HCl) was added to each well and the plates were further
incubated at 37 C overnight. Optical density was measured at
540/630 nm with Multiscan EX ELISA reader (Thermo
Labsystems, Waltham, MA) as described elsewhere (Takacs et al.
2015). Combination index (CI) values at 50% of the growth
inhibition dose (ED50) were determined using CompuSyn soft-
ware (ComboSyn, Inc., Paramus, NJ) to plot four to five data
points to each ratio. CI values were calculated by means of the
median-effect equation, where CI <1, CI ¼ 1 and CI >1 repre-
sent synergism, additive effect (or no interaction) and antagon-
ism, respectively (Chou and Martin 2005; Chou 2010).
Results
Isolated compounds
Repeated column chromatography of the bioactive fractions
resulted in the isolation of 13 compounds. The compounds were
identified by careful interpretation of NMR data and comparison
of 1H and 13C chemical shifts with those reported in literature.
Nine linear furocoumarin derivatives, namely pabulenol (1) (Sbai
et al. 2016), (þ)-oxypeucedanin hydrate (aviprin) (2) (Sbai et al.
2016), oxypeucedanin (3) (Sbai et al. 2016), oxypeucedanin
methanolate (4) (Fujioka et al. 1999), (–)-oxypeucedanin hydrate
(prangol) (5) (Rahimifard et al. 2018), imperatorin (6) (Lv et al.
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2013), isogospherol (7) (Macias et al. 1990), heraclenin (8)
(Poonkodi 2016), heraclenol (9) (Harkar et al. 1984); along with
vanillic aldehyde (10) (Chung et al. 2011), harmine (11),
3-hydroxy-a-ionone (12) and 2-C-methyl-erythrytol (13) were
identified (1H NMR spectra see in Supporting Information). The
diastereomers (þ)-oxypeucedanin hydrate and ()-oxypeuceda-
nin hydrate were distinguished by determining their optical rota-
tions and comparing with literature (Atkinson et al. 1974).
The 1H and 13C NMR spectral data of 11, 12 and 13 in
CD3OD are reported here for the first time. Compound 11 (har-
mine): 1H NMR (500MHz, CD3OD) d ¼ 8.11 (H-3, d,
J¼ 5.5Hz), 8.02 (H-5, d, J¼ 8.7Hz), 7.86 (H-4, d, J¼ 5.5Hz),
7.06 (H-8, d, J¼ 1.9Hz), 6.89 (H-6, dd, J¼ 8.7Hz, 1.9Hz), 3.92
(s, 7-OCH3), 2.80 (s, 1-CH3);
13C NMR (125MHz, CD3OD)
d ¼ 162.9, 144.6, 141.6, 137.0, 136.2, 130.7, 123.7, 116.3, 113.5,
111.4, 95.4, 56.0, 19.1. Compound 12 (3-hydroxy-a-ionone): 1H
NMR (500MHz, CD3OD) d ¼ 6.67 (H-7, dd, J¼ 15.8Hz,
10.3Hz), 6.13 (H-8, d, J¼ 15.8Hz), 5.60 (H-4, br s), 4.22 (H-3,
br s), 2.58 (H-6, d, J¼ 10.3Hz), 2.27 (H3-10, s), 1.80 (H-2b, dd,
J¼ 13.2Hz, 5.9Hz), 1.63 (H3-13, s), 1.38 (H-2a, dd,
J¼ 13.2Hz, 7.2Hz), 1.01 (H3-11, s), 0.90 (H3-12, s); 13C NMR
(125MHz, CD3OD) d ¼ 200.8, 149.8, 135.9, 134.7, 127.3, 65.9,
55.6, 45.0, 35.0, 29.8, 27.1, 24.5, 22.8. Compound 13 (2-C-
methyl-erythrytol): 1H NMR (500MHz, CD3OD) d ¼ 3.80 (H-4a,
dd, J¼ 10.4Hz, 2.5Hz), 3.61 (H-3, m), 3.59 (H-4b, m), 3.52 (H-
1a, d, J¼ 11.1Hz), 3.44 (H-1b, d, J¼ 11.1Hz), 1.11 (2-CH3, s);
13C NMR (125MHz, CD3OD) d ¼ 76.2, 75.0, 68.5, 63.8, 19.7.
Antiproliferative and cytotoxic activities on cancer cell lines
Furocoumarins isolated from D. anethifolia were subjected to
bioassay for cytotoxic and antiproliferative activity against cancer
cell lines. All compounds exerted potent antiproliferative effect
on sensitive and resistant mouse T-lymphoma cells (Table 1).
However, they did not show any selectivity towards the resistant
cell line. The most potent compound was oxypeucedanin on
both cell lines. Some compounds had no toxic effects ((þ)-oxy-
peucedanin hydrate (2), heraclenol (9), isogospherol (7)); fur-
thermore, pabulenol (1), oxypeucedanin methanolate (4) and
imperatorin (6) were more toxic on the sensitive PAR cell line
(IC50 between 52 and 57 mM) without any toxicity on MDR cells
(Table 1). Oxypeucedanin (3) and heraclenin (8) exhibited cyto-
toxic activity; however, they were more potent on the sensitive
PAR cell line (Table 1). The cytotoxic activity of furocoumarins
was assessed using NIH/3T3 normal murine fibroblast cells.
Some compounds showed slight toxic effect on normal fibro-
blasts, namely (þ)-oxypeucedanin hydrate (2), heraclenol (4) and
isogospherol (8) with IC50 values of 83.55, 65.78 and 54.82 mM,
respectively. Pabulenol (1) possessed similar activity on fibroblast
and parental mouse lymphoma cells. In addition, oxypeucedanin
(3), oxypeucedin methanolate (5) and heraclenin (9) exhibited
mild toxicity on fibroblasts and parental lymphoma cells.
Imperatorin (7) had no toxic activity on fibroblasts.
Multidrug resistance reversing activity
Regarding the efflux pump inhibiting activity of the compounds
on ABCB1 overexpressing MDR mouse T-lymphoma cells, only
oxypeucedanin (3) showed moderate ABCB1 inhibiting effect
(FAR: 2.22); however, this inhibition was lower than in case of
the positive controls tariquidar (FAR: 100) and verapamil (FAR:
8.2) (Table 2, figures see in Supporting Information).
Combination assay results on MDR cells
The two most promising compounds in the previous assays were
investigated in combination with the standard chemotherapeutic
drug doxorubicin. The compounds oxypeucedanin (3) and hera-
clenin (8) showed slight synergistic effect with doxorubicin, for
this reason, they might be potential adjuvants in combined
chemotherapy applying standard anticancer drugs with com-
pounds that can act synergistically (Table 3).
Table 1. Antiproliferative (AA) and cytotoxic activities (CA) of the furocoumarins against PAR, MDR and NIH/3T3 cells presented as IC50 values.
Compounds AA on PAR cells (mM) AA on MDR cells (mM) CA on PAR cells (mM) CA on MDR cells (mM) CA on NIH/3T3cells (mM)
Pabulenol (1) 30.47 ± 0.47 29.28 ± 0.45 51.32 ± 3.32 >100 54.09 ± 3.83
(þ)-Oxypeucedanin hydrate (2) 41.96 ± 0.88 60.58 ± 2.74 >100 >100 83.55 ± 0.57
Oxypeucedanin (3) 25.98 ± 1.27 28.89 ± 0.73 40.33 ± 0.63 66.68 ± 0.00 57.18 ± 3.91
Oxypeucedanin methanolate (4) 35.88 ± 0.96 33.23 ± 0.51 56.42 ± 5.23 >100 47.16 ± 1.28
Imperatorin (6) 36.12 ± 0.91 42.24 ± 0.88 52.56 ± 4.19 >100 92.41 ± 2.80
Isogospherol (7) 46.53 ± 0.47 48.75 ± 0.28 >100 >100 54.82 ± 1.99
Heraclenin (8) 32.73 ± 2.40 46.54 ± 1.22 65.81 ± 1.00 83.94 ± 1.68 70.91 ± 4.26
Heraclenol (9) 52.31 ± 2.12 46.57 ± 0.47 >100 >100 65.78 ± 0.46
Doxorubicin 0.054 ± 0.005 0.468 ± 0.065 0.377 ± 0.02 7.152 ± 0.358 5.71 ± 0.50
Data were expressed as mean ± standard deviation (n¼ 3). Different letters represent significant differences (p< 0.05).
Table 2. Efflux pump inhibiting activities of furocoumarins.
Samples Conc. lM FSC SSC FL-1 FAR
PAR – 2069 658 98.20 –
MDR – 2152 725 1.79 –
MDR mean 1.182 –
Tariquidar 0.02 2156 719 119 100.68
Verapamil 20 2143 740 9.69 8.20
Pabulenol (1) 2 2324 728 0.596 0.82
20 2323 750 0.544 0.75
(þ)-Oxypeucedanin hydrate (2) 2 2325 725 0.715 0.98
20 2305 769 0.583 0.80
Oxypeucedanin (3) 2 2190 749 0.9 0.76
20 2164 763 2.62 2.22
Oxypeucedanin methanolate (4) 2 2310 737 0.58 0.80
20 2290 766 0.499 0.68
Imperatorin (6) 2 2165 749 0.727 0.62
20 2161 750 0.783 0.66
Isogospherol (7) 2 2305 741 0.531 0.73
20 2326 741 0.548 0.75
Heraclenin (8) 2 2318 723 0.942 1.29
20 2294 764 0.57 0.78
Heraclenol (9) 2 2300 742 0.995 1.37
20 2317 740 0.348 1.30
DMSO 2% (V/V) 2308 762 0.497 0.68
MDR – 2301 746 0.535 –
Table 3. Checkerboard combination assay of selected compounds with
doxorubicin.
Compound Best ratio CI at ED50 Interaction SD (±)
Oxypeucedanin 1:50 0.85537 Slight synergism 0.07800
Heraclenin 4:100 0.88955 Slight synergism 0.06334
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Discussion
Chromatographic separation of the extract of D. anethifolia herbs
resulted in the isolation of 13 compounds, among them were
nine furocoumarins. Compounds 2, 3, 5, 7, 10–13 were identi-
fied for the first time from Ducrosia genus.
The tested furocoumarins exerted antiproliferative effects on
sensitive and resistant mouse T-lymphoma cells with no selectiv-
ity towards the resistant cell line. This is the first comprehensive
analysis of this plant and its furocoumarins on these cells.
Oxypeucedanin (3) had the most remarkable activity on both cell
lines. The most effective furocoumarins, oxypeucedanin (3) and
heraclenin (9) exhibited marginal toxicity on normal fibroblast
cells and sensitive parental mouse lymphoma cells; furthermore,
they were less toxic on multidrug resistant lymphoma cells.
From the tested compounds, only oxypeucedanin showed moder-
ate MDR reversing activity. In the checkerboard assay, oxypeuce-
danin and heraclenin showed slight synergistic effect with
doxorubicin. These compounds might improve the cytotoxic
effect of the standard chemotherapeutic drug doxorubicin.
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